Effect of HLA Class II Gene Disparity on Clinical Outcome in Unrelated Donor Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia: The US National Marrow Donor Program Experience

Blood - United States
doi 10.1182/blood.v98.10.2922